Healthstream (HSTM) Receivables - Other (2010 - 2026)

Healthstream (HSTM) has reported Receivables - Other for 13 consecutive years, with $5.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables - Other rose 24.66% year-over-year to $5.7 million in Q2 2026; TTM through Jun 2026 was $5.7 million, a 24.66% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 33.35% from the prior year.
• Receivables - Other was $5.7 million for Q2 2026 at Healthstream, up from $5.0 million in the prior quarter.
• Over five years, Receivables - Other peaked at $6.8 million in Q4 2025 and troughed at $4.1 million in Q4 2023.
• A 5-year average of $5.4 million and a median of $5.3 million in 2024 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other jumped 66.3% in 2022 and slumped 31.44% in 2023, its largest moves.
• Over 5 years, Receivables - Other stood at $6.0 million in 2022, then tumbled by 31.44% to $4.1 million in 2023, then increased by 25.2% to $5.1 million in 2024, then jumped by 33.35% to $6.8 million in 2025, then declined by 17.3% to $5.7 million in 2026.
• The last three Receivables - Other figures came in at $5.7 million (Q2 2026), $5.0 million (Q1 2026), and $6.8 million (Q4 2025), per Business Quant data.